Lee's Pharmaceutical Holdings Limited

OTCPK:LPCU.F Stock Report

Market Cap: US$111.5m

Lee's Pharmaceutical Holdings Past Earnings Performance

Past criteria checks 3/6

Lee's Pharmaceutical Holdings's earnings have been declining at an average annual rate of -43.2%, while the Pharmaceuticals industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 1.3% per year. Lee's Pharmaceutical Holdings's return on equity is 3.5%, and it has net margins of 6.8%.

Key information

-43.22%

Earnings growth rate

-43.22%

EPS growth rate

Pharmaceuticals Industry Growth5.95%
Revenue growth rate1.31%
Return on equity3.53%
Net Margin6.81%
Last Earnings Update30 Jun 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Lee's Pharmaceutical Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:LPCU.F Revenue, expenses and earnings (HKD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 251,4369858191
31 Mar 251,4189558988
31 Dec 241,4009359684
30 Sep 241,3007856183
30 Jun 241,1996352682
31 Mar 241,1264051089
31 Dec 231,0531749497
30 Sep 23980547275
30 Jun 231,09639495101
31 Mar 231,16539520132
31 Dec 221,23351545169
30 Sep 221,350-119717230
30 Jun 221,331-140753248
31 Mar 221,3081,966766258
31 Dec 211,2661,987754244
30 Sep 211,2752,176626241
30 Jun 211,2442,188574241
31 Mar 211,227130534226
31 Dec 201,217129519203
30 Sep 201,199167522177
30 Jun 201,168184512146
31 Mar 201,209118508141
31 Dec 191,219126491150
30 Sep 191,185301471174
30 Jun 191,177331442168
31 Mar 191,139395403156
31 Dec 181,138418411153
30 Sep 181,126243380123
30 Jun 181,101233377112
31 Mar 181,06425639396
31 Dec 171,00923337185
30 Sep 1798124534877
30 Jun 1795525634772
31 Mar 1793024534874
31 Dec 1693025235168
30 Sep 1691125933761
30 Jun 1689424733250
31 Mar 1691724234841
31 Dec 1592222936939
30 Sep 1597622141532
30 Jun 1599020943537
31 Mar 1597919142640

Quality Earnings: LPCU.F has a large one-off loss of HK$26.2M impacting its last 12 months of financial results to 30th June, 2025.

Growing Profit Margin: LPCU.F's current net profit margins (6.8%) are higher than last year (5.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: LPCU.F's earnings have declined by 43.2% per year over the past 5 years.

Accelerating Growth: LPCU.F's earnings growth over the past year (55.1%) exceeds its 5-year average (-43.2% per year).

Earnings vs Industry: LPCU.F earnings growth over the past year (55.1%) exceeded the Pharmaceuticals industry 7%.

Return on Equity

High ROE: LPCU.F's Return on Equity (3.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/17 17:41
End of Day Share Price 2025/11/20 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lee's Pharmaceutical Holdings Limited is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chu WangCitigroup Inc
Jun Zhou LiEverbright Securities Co. Ltd.
Yue-Kwong LuiJefferies LLC